US Tecentriq Market Demand Trends in Immune Checkpoint Inhibitor...

hat ein neuen Blog hinzugefügt Andere

2026-10-27 11:06:39 - Übersetzen -

US Tecentriq Market Demand Trends in Immune Checkpoint Inhibitor Therapy by 2034

US Tecentriq Market growth is supported by the use of atezolizumab in approved cancer treatment settings and continued investment in oncology care. The medicine is used for selected patients with non-small cell lung cancer, small cell lung cancer, and other cancers according to US prescribing information. The Tecentriq Market size is projected to reach US$ 12.55 million by 2034 from US$ 4.29...

0 Kommentare 0 Geteilt 122 Ansichten 0 Bewertungen